X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (54136) 54136
Publication (6373) 6373
Book Review (5339) 5339
Newsletter (3893) 3893
Book Chapter (254) 254
Conference Proceeding (161) 161
Book / eBook (127) 127
Magazine Article (93) 93
Newspaper Article (63) 63
Trade Publication Article (39) 39
Dissertation (12) 12
Data Set (7) 7
Transcript (5) 5
Reference (3) 3
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (51375) 51375
humans (29182) 29182
animals (26214) 26214
mice (11843) 11843
virology (10523) 10523
immunology (10313) 10313
cell line (9161) 9161
antibodies (9069) 9069
female (8784) 8784
viruses (8099) 8099
pharmacology & pharmacy (7794) 7794
viral antibodies (7673) 7673
antiviral agents - pharmacology (7158) 7158
proteins (7136) 7136
medicine, research & experimental (6793) 6793
health aspects (6511) 6511
male (6308) 6308
research (5879) 5879
vaccines (5860) 5860
biochemistry & molecular biology (5800) 5800
infection (5788) 5788
analysis (5267) 5267
molecular sequence data (5156) 5156
virus diseases (4974) 4974
virus replication - drug effects (4882) 4882
infections (4801) 4801
cells, cultured (4596) 4596
microbiology (4426) 4426
mutation (4290) 4290
expression (4255) 4255
infectious diseases (4038) 4038
antiviral agents (3796) 3796
amino acid sequence (3720) 3720
replication (3535) 3535
gene expression (3508) 3508
cell biology (3500) 3500
research article (3407) 3407
cells (3350) 3350
base sequence (3321) 3321
multidisciplinary sciences (3301) 3301
article (3240) 3240
mice, inbred balb c (3224) 3224
hiv (3219) 3219
medicine (3202) 3202
adult (3196) 3196
medical research (3176) 3176
viral proteins - metabolism (3171) 3171
in-vitro (3120) 3120
dna (2995) 2995
viral proteins - genetics (2992) 2992
antigens (2937) 2937
biotechnology & applied microbiology (2926) 2926
rna (2899) 2899
virus replication (2842) 2842
cancer (2831) 2831
allergy and immunology (2819) 2819
kinetics (2767) 2767
transfection (2746) 2746
viral proteins (2745) 2745
protein (2705) 2705
vaccination (2666) 2666
influenza (2616) 2616
middle aged (2593) 2593
cell line, tumor (2590) 2590
in-vivo (2537) 2537
immunization (2533) 2533
science (2512) 2512
viral infections (2488) 2488
apoptosis (2476) 2476
protein binding (2392) 2392
antibodies, viral - blood (2391) 2391
time factors (2381) 2381
aids/hiv (2373) 2373
rats (2372) 2372
hiv-1 - drug effects (2346) 2346
genes (2279) 2279
viral proteins - biosynthesis (2253) 2253
biology (2242) 2242
activation (2229) 2229
genetic aspects (2228) 2228
pharmacology (2210) 2210
hela cells (2202) 2202
oncology (2148) 2148
medicine, experimental (2139) 2139
interferon (2054) 2054
enzyme-linked immunosorbent assay (2042) 2042
hiv-1 - genetics (2038) 2038
antiviral agents - therapeutic use (2034) 2034
physiological aspects (2034) 2034
t cells (2030) 2030
binding sites (2023) 2023
cercopithecus aethiops (1962) 1962
veterinary sciences (1944) 1944
mice, inbred c57bl (1937) 1937
identification (1934) 1934
studies (1932) 1932
lymphocytes (1927) 1927
vaccine (1925) 1925
immune response (1924) 1924
viral vaccines - immunology (1912) 1912
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (89) 89
Collection Dvlpm't (Acquisitions) - Closed Orders (9) 9
Collection Dvlpm't (Acquisitions) - Vendor file (9) 9
UTL at Downsview - May be requested (5) 5
Online Resources - Online (4) 4
UofT at Mississauga - Stacks (3) 3
Earth Sciences (Noranda) - Stacks (2) 2
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (2) 2
UofT at Scarborough - Stacks (2) 2
Dentistry (Harry R Abbott) - May be requested in 6-10 wks (1) 1
Gerstein Science - Course Reserves (1) 1
Law (Bora Laskin) - Stacks (1) 1
Robarts - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
UofT at Mississauga - Periodical Stacks (1) 1
West Park Healthcare Centre - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (57545) 57545
Russian (312) 312
Chinese (186) 186
Japanese (118) 118
German (82) 82
French (75) 75
Spanish (57) 57
Polish (14) 14
Italian (9) 9
Bulgarian (6) 6
Hungarian (5) 5
Ukrainian (4) 4
Czech (3) 3
Portuguese (3) 3
Danish (2) 2
Dutch (2) 2
Turkish (2) 2
Finnish (1) 1
Hebrew (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Immunity, ISSN 1074-7613, 2006, Volume 25, Issue 4, pp. 607 - 617
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2018, Volume 24, Issue 2, pp. 203 - 212
Intratumor heterogeneity is a key factor contributing to therapeutic failure and, hence, cancer lethality. Heterogeneous tumors show partial therapy responses,... 
MEDICINE, RESEARCH & EXPERIMENTAL | BIOCHEMISTRY & MOLECULAR BIOLOGY | ACQUIRED-RESISTANCE | IMPROVED SURVIVAL | MONOCLONAL-ANTIBODY | MAPK PATHWAY INHIBITORS | MESENCHYMAL TRANSITION | CANCER-THERAPY | CELL BIOLOGY | MUTATED MELANOMA | MEK INHIBITION | UP-REGULATION | RECEPTOR TYROSINE KINASE | Humans | Receptor Protein-Tyrosine Kinases - immunology | Proto-Oncogene Proteins - chemistry | Immunoconjugates - immunology | Immunoconjugates - pharmacology | Protein Kinase Inhibitors - chemistry | Melanoma - genetics | Protein Kinase Inhibitors - immunology | Proto-Oncogene Proteins - immunology | Oligopeptides - chemistry | Proto-Oncogene Proteins - pharmacology | Genetic Heterogeneity - drug effects | Oligopeptides - immunology | Receptor Protein-Tyrosine Kinases - pharmacology | Drug Resistance, Neoplasm - immunology | Melanoma - pathology | Proto-Oncogene Proteins B-raf - antagonists & inhibitors | Xenograft Model Antitumor Assays | Animals | Melanoma - immunology | Proto-Oncogene Proteins B-raf - genetics | Melanoma - drug therapy | Proto-Oncogene Proteins B-raf - immunology | Cell Line, Tumor | Mice | Protein Kinase Inhibitors - pharmacology | Oligopeptides - pharmacology | Receptor Protein-Tyrosine Kinases - chemistry | Drug Resistance, Neoplasm - drug effects | Viral antibodies | Complications and side effects | Melanoma | Antibodies | Dosage and administration | Genetic aspects | Research | Drug therapy | Biopharmaceutics | Therapy | Populations | Inhibitor drugs | Transcription | Lung | Lung cancer | Lethality | Drug resistance | Axl protein | Anticancer properties | Heterogeneity | Antitumor agents | Xenografts | Protein-tyrosine kinase receptors | Pancreas | Protein-tyrosine kinase | Tyrosine | MEK inhibitors | MAP kinase | Cervix | Inhibitors | Pancreatic cancer | Monoclonal antibodies | Combinatorial analysis | Cervical cancer | Tumors | Cancer | Index Medicus
Journal Article
Nature, ISSN 0028-0836, 10/2015, Volume 526, Issue 7572, pp. 218 - 223
HIV-1 Nef and the unrelated mouse leukaemia virus glycosylated Gag (glycoGag) strongly enhance the infectivity of HIV-1 virions produced in certain cell types... 
CYTOPLASMIC DOMAIN | CELL-SURFACE CD4 | GLYCOSYLATED-GAG | VIRION FUSION | REPLICATION | PRIMARY T-LYMPHOCYTES | MULTIDISCIPLINARY SCIENCES | IMMUNODEFICIENCY-VIRUS TYPE-1 | CD4 DOWN-REGULATION | MURINE LEUKEMIA-VIRUS | OPTIMAL VIRAL INFECTIVITY | Humans | Neoplasm Proteins - antagonists & inhibitors | Neoplasm Proteins - pharmacology | Virion - chemistry | Host-Pathogen Interactions - drug effects | Membrane Proteins - pharmacology | Neoplasm Proteins - metabolism | Receptors, Cell Surface - antagonists & inhibitors | Membrane Proteins - deficiency | HIV-1 - growth & development | HIV-1 - physiology | HIV-1 - chemistry | Gene Deletion | nef Gene Products, Human Immunodeficiency Virus - metabolism | Membrane Proteins - metabolism | Cell Line | Virus Replication - drug effects | nef Gene Products, Human Immunodeficiency Virus - deficiency | HIV-1 - drug effects | Down-Regulation | HIV Infections - virology | Virion - physiology | CD4-Positive T-Lymphocytes - metabolism | Receptors, Cell Surface - metabolism | Gene Products, gag - metabolism | Protein Transport | Virion - drug effects | Membrane Proteins - antagonists & inhibitors | Receptors, Cell Surface - deficiency | HIV Infections - drug therapy | Neoplasm Proteins - deficiency | Virion - growth & development | Leukemia Virus, Murine - chemistry | Development and progression | Genetic aspects | Virulence (Microbiology) | Viral proteins | Properties | HIV infection | Proteins | Genomes | Immunology | Mutation | Human immunodeficiency virus--HIV | Cells | Index Medicus
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 03/2013, Volume 57, Issue 3, pp. 1312 - 1322
Journal Article
Journal of Hepatology, ISSN 0168-8278, 2014, Volume 62, Issue 5, pp. 1008 - 1014
Journal Article
Nature Medicine, ISSN 1078-8956, 02/2017, Volume 23, Issue 2, pp. 256 - 263
The cytostatic deoxycytidine analog cytarabine (ara-C) is the most active agent available against acute myelogenous leukemia (AML). Together with... 
MEDICINE, RESEARCH & EXPERIMENTAL | CYTOSINE-ARABINOSIDE | CELLS | ARA-C SENSITIVITY | BIOCHEMISTRY & MOLECULAR BIOLOGY | ACUTE MYELOID-LEUKEMIA | DRUG-RESISTANCE | CELL BIOLOGY | IN-VITRO | DNA | CHRONIC LYMPHOCYTIC-LEUKEMIA | MUTATIONS | EXPRESSION | Cytarabine - pharmacology | Prognosis | Apoptosis - drug effects | Cytarabine - therapeutic use | Humans | Leukemia, Myeloid, Acute - metabolism | SAM Domain and HD Domain-Containing Protein 1 | Child, Preschool | Infant | Male | Viral Regulatory and Accessory Proteins - pharmacology | Molecular Targeted Therapy | Monomeric GTP-Binding Proteins - drug effects | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Aged, 80 and over | Leukemia, Myeloid, Acute - drug therapy | Adult | Antimetabolites, Antineoplastic - pharmacology | Female | Child | Disease Models, Animal | Arabinofuranosylcytosine Triphosphate - metabolism | Antimetabolites, Antineoplastic - therapeutic use | Animals | Monomeric GTP-Binding Proteins - metabolism | Adolescent | Aged | Mice | In Vitro Techniques | Cellular proteins | Molecular targeted therapy | Care and treatment | Cytarabine | Patient outcomes | Drug interactions | Innovations | Development and progression | Genetic aspects | Blood diseases | Health aspects | Biomarkers | Cytotoxicity | Chemotherapy | Gene expression | Leukemia | Index Medicus | Biological Sciences | Clinical Medicine | Naturvetenskap | Medical and Health Sciences | Hematology | Hematologi | Medicin och hälsovetenskap | Biologiska vetenskaper | Natural Sciences | Klinisk medicin
Journal Article
PLoS ONE, ISSN 1932-6203, 10/2013, Volume 8, Issue 10, pp. e78355 - e78355
Approximately 30% of patients with Epstein-Barr virus (EBV)-positive advanced nasopharyngeal carcinoma (NPC) display chemoresistance to cisplatin-based... 
CANCER-CELLS | B-CELLS | SURVIVAL | MEMBRANE-PROTEIN 1 | MULTIDISCIPLINARY SCIENCES | EBV | MIR-21 | LATENCY | LIGAND | EXPRESSION | LINES | RNA-Binding Proteins - genetics | Carcinoma | Apoptosis - drug effects | Humans | Nasopharyngeal Neoplasms - virology | MicroRNAs - metabolism | Viral Matrix Proteins - pharmacology | Tetrazolium Salts | Forkhead Transcription Factors - metabolism | Luciferases | Thiazoles | Apoptosis Regulatory Proteins - genetics | Inhibitory Concentration 50 | Viral Matrix Proteins - metabolism | Colony-Forming Units Assay | Gene Expression Regulation, Neoplastic - drug effects | Nasopharyngeal Neoplasms - drug therapy | Real-Time Polymerase Chain Reaction | RNA-Binding Proteins - antagonists & inhibitors | Cell Line | Nasopharyngeal Carcinoma | Cisplatin - pharmacology | Reverse Transcriptase Polymerase Chain Reaction | Blotting, Western | Drug Resistance, Neoplasm - genetics | Fas Ligand Protein - antagonists & inhibitors | Cisplatin - therapeutic use | Signal Transduction - drug effects | Apoptosis Regulatory Proteins - antagonists & inhibitors | Fluorescent Antibody Technique | MicroRNAs - genetics | Fas Ligand Protein - genetics | Forkhead Box Protein O3 | Infection | Prognosis | MicroRNA | Tumor necrosis factor | Epstein-Barr virus | B cells | Health aspects | Cisplatin | Apoptosis | Cancer | Cell proliferation | Laboratories | Genes | Crosstalk | Chemoresistance | Viruses | Oncology | Homology | AKT protein | Infections | Metastasis | Proteins | Nasopharyngeal carcinoma | Disease resistance | Signal transduction | Coding | Tumor necrosis factor-TNF | Tumorigenesis | Bioindicators | FOXO3 protein | MiRNA | Ribonucleic acid--RNA | 1-Phosphatidylinositol 3-kinase | Membrane proteins | Medicine | Signaling | Chemotherapy | FasL protein | Cell death | MicroRNAs | Medical prognosis | Cell lines | Biomarkers | Ligands | Latent membrane protein 1 | Index Medicus | RNA | Ribonucleic acid
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 3/2015, Volume 112, Issue 9, pp. E992 - E999
Journal Article